*ST国华(000004.SZ)：国科稚健拟以104万元对润乐药业进行增资

Core Viewpoint - *ST Guohua announced that its subsidiary, Shenzhen Guoke Zhijian Pharmaceutical Co., Ltd., has signed a capital increase agreement with Zhongshan Runle Pharmaceutical Co., Ltd., indicating a strategic investment to enhance its stake in the pharmaceutical sector [1] Group 1 - The company plans to invest 1.04 million yuan in Runle Pharmaceutical [1] - After the capital increase, Guoke Zhijian will hold 50.9804% equity in Runle Pharmaceutical [1] - Runle Pharmaceutical will be included in the company's consolidated financial statements following the completion of the investment [1]